Drug profile · INN
trolamine polypeptide oleate condensate
CERUMENEX
trolamine polypeptide oleate condensate (CERUMENEX) is an FDA-listed pharmaceutical active ingredient. Route of administration: otic. Current US regulatory status: approved.
Drug details — trolamine polypeptide oleate condensate
- US status
- approved
- Class
- —
- Route
- OTIC
- Patents
- 1
- Programs
- 2
- Data quality
- 0.84
Quick answer
trolamine polypeptide oleate condensate (CERUMENEX) is an FDA-listed pharmaceutical active ingredient. Route of administration: otic. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related patents
Frequently asked questions
What is trolamine polypeptide oleate condensate?
trolamine polypeptide oleate condensate (CERUMENEX) is an FDA-listed pharmaceutical active ingredient. Route of administration: otic. Current US regulatory status: approved.
What is the brand name for trolamine polypeptide oleate condensate?
CERUMENEX is a marketed brand name for trolamine polypeptide oleate condensate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trolamine polypeptide oleate condensate?
trolamine polypeptide oleate condensate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.